Tardive dystonia and tardive sensory syndrome related to trazodone: A case report

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 6, 2008, Pages 1609-1610

  Lin, Chin Chuen ^a   Lin, Pao Yen ^a   Chang, Yung Yee ^a   Chen, Cheng Hsing ^b   Lee, Yu ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b Hsing Ann Clinic   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CLONAZEPAM; MIRTAZAPINE; TRAZODONE;

ADULT; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFECT; DRUG INDICATION; DRUG WITHDRAWAL; DYSARTHRIA; DYSTONIA; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; LETTER; ORAL PARESTHESIA; SENSORY DYSFUNCTION; TARDIVE DYSTONIA; TARDIVE SENSORY SYNDROME; TOOTH PAIN; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; CLONAZEPAM; DYSKINESIA, DRUG-INDUCED; DYSTONIA; FEMALE; HUMANS; JAW; NEUROLOGIC EXAMINATION; TRAZODONE;

EID: 47749087773     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.05.002     Document Type: Letter

References (16)

1. Alonso-Navarro H., and Jimenez-Jimenez F.J. Tardive blepharospasm associated with cinnarizine use. Clin Neuropharmacol 29 (2006) 187-189
2. Ananth J., Swartz R., Chung C., and Gadasally R. Dysarthria: lonely symptom of tardive dystonia. Can J Psychiatry 42 (1997) 428-429
3. Boffa E., and Lofchy J. Paroxetine and tardive akathisia. Can J Psychiatry 45 (2000) 196
4. Burke R.E., Fahn S., Jankovic J., Marsden C.D., Lang A.E., Gollomp S., et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 32 (1982) 1335-1346
5. Dannon P.N., Grunhaus L., Iancu I., Braf A., and Lepkifker E. Vitamin E treatment in tardive dystonia. Clin Neuropharmacol 20 (1997) 434-437
6. Fernandez H.H., and Friedman J.H. Classification and treatment of tardive syndromes. Neurologist 9 (2003) 16-27
7. Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol 18 (1995) 197-214
8. Kramer M.S., Marcus D.J., DiFerdinando J., and Dewey D. Atypical acute dystonia associated with trazodone treatment. J Clin Psychopharmacol 6 (1986) 117-118
9. Kraus R.L., Li Y., Jovanovska A., and Renger J.J. Trazodone inhibits T-type calcium channels. Neuropharmacology 53 (2007) 308-317
10. Lewis C.F., DeQuardo J.R., and Tandon R. Dystonia associated with trazodone and sertraline. J Clin Psychopharmacol 17 (1997) 64-65
11. Lipinski Jr. J.F., Mallya G., Zimmerman P., and Pope Jr. H.G. Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry 50 (1989) 339-342
12. Remington G.J. The Pisa syndrome: possible role for serotonin and noradrenaline. J Clin Psychopharmacol 8 (1988) 228-229
13. Sandler N.H. Tardive dyskinesia associated with fluoxetine. J Clin Psychiatry 57 (1996) 91
14. Schooler N.R., and Kane J.M. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39 (1982) 486-487
15. Soares-Weiser K., and Rathbone J. Calcium channel blockers for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev (2004) CD000206
16. Terland O., and Flatmark T. Drug-induced parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles. Neuropharmacology 38 (1999) 879-882